Plain-English translation of NCT06012695 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This trial is testing a new medication called NBM-BMX to see if it can help treat cancer. The study has two parts: one for patients with advanced solid tumors who would take NBM-BMX alone, and another for patients newly diagnosed with glioblastoma (a serious brain cancer) who would take this medication alongside standard radiation and chemotherapy treatments.
Current treatments for advanced cancers and glioblastoma have limited effectiveness for many patients. Researchers believe this new medication might improve how well standard treatments work or offer benefit when other options are no longer working.
You likely qualify if…
You likely don't qualify if…
You would take NBM-BMX as a pill by mouth, either alone (if you have advanced solid tumors) or alongside your regular radiation and chemotherapy (if you have newly diagnosed glioblastoma). You'll have regular clinic visits for check-ups, blood tests, and scans to monitor how well the treatment is working and check for any side effects. The exact length and frequency of visits will depend on which group you're in and how your cancer responds.
AI-generated summary from trial data · Aug 2, 2026 · Not medical advice
Taiwan